Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 1
1994 1
1995 3
1996 1
1997 1
1998 2
1999 4
2003 1
2007 1
2009 1
2010 1
2011 2
2012 1
2013 2
2014 1
2015 1
2016 1
2017 3
2018 4
2019 1
2020 3
2021 7
2022 12
2023 5
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
La terapia immunosoppressiva erogata ai pazienti dopo trapianto di cuore o polmone: lo studio Cesit.
Rosa AC, Finocchietti M, Bellini A, Oliveti A, Peritore D, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Massari M, Spila Alegiani S, Leoni O, Mazzone A, Ferroni E, Pierobon S, Ledda S, Garau D, Addis A. Rosa AC, et al. Among authors: spila alegiani s. Recenti Prog Med. 2023 Sep;114(9):523-524. doi: 10.1701/4088.40795. Recenti Prog Med. 2023. PMID: 37530002 Italian. No abstract available.
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.
Lombardo FL, Spila Alegiani S, Mayer F, Cipriani M, Lo Giudice M, Ludolph AC, McDermott CJ, Corcia P, Van Damme P, Van den Berg LH, Hardiman O, Nicolini G, Vanacore N, Dickie B, Albanese A, Puopolo M; TUDCA-ALS Study Group. Lombardo FL, et al. Among authors: spila alegiani s. Trials. 2023 Dec 5;24(1):792. doi: 10.1186/s13063-023-07638-w. Trials. 2023. PMID: 38053196 Free PMC article. Clinical Trial.
Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project).
Rosa AC, Finocchietti M, Agabiti N, Menè P, Bracaccia ME, Bellini A, Massari M, Spila Alegiani S, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Piccolo G, Leoni O, Ferroni E, Pierobon S, Nordio M, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT study group. Rosa AC, et al. Among authors: spila alegiani s. BMC Nephrol. 2023 Oct 27;24(1):320. doi: 10.1186/s12882-023-03325-9. BMC Nephrol. 2023. PMID: 37891504 Free PMC article.
Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study.
Bellini A, Finocchietti M, Rosa AC, Nordio M, Ferroni E, Massari M, Spila Alegiani S, Masiero L, Bedeschi G, Cardillo M, Lucenteforte E, Piccolo G, Leoni O, Pierobon S, Ledda S, Garau D, Davoli M, Addis A, Belleudi V; CESIT study group. Bellini A, et al. Among authors: spila alegiani s. PLoS One. 2024 Jan 2;19(1):e0295205. doi: 10.1371/journal.pone.0295205. eCollection 2024. PLoS One. 2024. PMID: 38165971 Free PMC article.
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network.
Spini A, Pellegrini G, Ingrasciotta Y, L'Abbate L, Bellitto C, Carollo M, Leoni O, Zanforlini M, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Spila Alegiani S, Massari M, Guarneri C, Gisondi P, Trifirò G. Spini A, et al. Among authors: spila alegiani s. Expert Opin Biol Ther. 2024 May;24(5):399-409. doi: 10.1080/14712598.2024.2357381. Epub 2024 May 21. Expert Opin Biol Ther. 2024. PMID: 38767132
Use of antipsychotics and long-term risk of parkinsonism.
d'Errico A, Strippoli E, Vasta R, Ferrante G, Spila Alegiani S, Ricceri F. d'Errico A, et al. Among authors: spila alegiani s. Neurol Sci. 2022 Apr;43(4):2545-2553. doi: 10.1007/s10072-021-05650-z. Epub 2021 Oct 15. Neurol Sci. 2022. PMID: 34652577 Free PMC article.
Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study.
Morciano C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, Trifirò G, Zanoni G, Puccini A, Sapigni E, Mores N, Leoni O, Monaco G, Clagnan E, Zappetti C, Bovo E, Cutillo M, Da Cas R, Massari M. Morciano C, et al. Among authors: spila alegiani s. PLoS One. 2024 Jan 19;19(1):e0290879. doi: 10.1371/journal.pone.0290879. eCollection 2024. PLoS One. 2024. PMID: 38241309 Free PMC article.
[Human papillomavirus vaccine register].
Spila-Alegiani S, Da Cas R, Giambi C, Raschetti R, Salmaso S. Spila-Alegiani S, et al. Recenti Prog Med. 2013 Jun;104(6):262-6. doi: 10.1701/1295.14327. Recenti Prog Med. 2013. PMID: 23801230 Italian.
Microbiologically confirmed infections and antibiotic-resistance in a national surveillance study of hospitalised patients who died with COVID-19, Italy 2020-2021.
Floridia M, Giuliano M, Monaco M, Palmieri L, Lo Noce C, Palamara AT, Pantosti A, Brusaferro S, Onder G; Italian National Institute of Health COVID-19 Mortality Group. Floridia M, et al. Antimicrob Resist Infect Control. 2022 May 21;11(1):74. doi: 10.1186/s13756-022-01113-y. Antimicrob Resist Infect Control. 2022. PMID: 35598032 Free PMC article. Review.
68 results